Tweetovi

Blokirali ste korisnika/cu @AiCuris

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AiCuris

  1. Prikvačeni tweet
    3. velj

    Why does it take so long to develop a drug? - gives the answer to this question in a German TV documentary :

    Poništi
  2. 21. stu 2019.

    Just in time with the WHO World Antibiotic Awareness Week , AiCuris reaffirmed its commitment to tackle one of the most scaring threats of the 21st century – antimicrobial resistant bacteria - at a BIO-Europe AMR panel. ;

    Poništi
  3. proslijedio/la je Tweet
    11. stu 2019.
    Poništi
  4. proslijedio/la je Tweet
    11. stu 2019.

    . Vorstand Holger Zimmermann diskutiert auf zum Thema Antibiotika

    Poništi
  5. 12. stu 2019.

    Anti-infective Cures GmbH today provided a strategic update, outlining its recent achievements and plans for future growth -

    Poništi
  6. proslijedio/la je Tweet
    8. stu 2019.

    Great panel discussion with Marc Gitzinger and about financing and the new impact investment fund at .

    Poništi
  7. 6. stu 2019.

    to attend ® and participate in AMR panel discussing the high medical need for novel antibiotics against the backdrop of challenging economic perspectives. Interested in meeting the management? Please follow the link for more info -

    Poništi
  8. 12. lis 2019.

    Thanks ! It‘s a honor for us to be awarded as Wuppertal‘s „Company of the year“. We‘re looking forward to investing further in this city.

    Poništi
  9. 12. lis 2019.

    Thank you Bernward Garthoff for all your efforts for the Biotech industry in NRW!

    Poništi
  10. 11. lis 2019.

    AiCuris, being awarded with the "Wuppertaler Wirtschaftspreis” as “Company of the year”.

    Poništi
  11. 13. ruj 2019.

    NDR reports on the growing threat of multidrug-resistant germs, missing effective antibiotics and pharmaceutical companies withdrawing from the development of new active ingredients. But this is not true for AiCuris. Read full statement (German):

    Poništi
  12. proslijedio/la je Tweet
    13. ruj 2019.

    NDR reports on the growing threat of multidrug-resistant germs, missing effective antibiotics and pharmaceutical companies withdrawing from the development of new active ingredients. But this is not true for AiCuris. Read full statement (German):

    Poništi
  13. 13. ruj 2019.

    NDR reports on the growing threat of multidrug-resistant germs, missing effective antibiotics and pharmaceutical companies withdrawing from the development of new active ingredients. But this is not true for AiCuris. Read full statement (German):

    Poništi
  14. 12. ruj 2019.

    Congrats to Prof. Rübsamen-Schaeff, Dr. Zimmermann and our entire scientific team. It's a great honor that is now part of the biggest science museum of the world.

    Poništi
  15. 12. ruj 2019.

    As winners of the German Future Prize 2018, Prof. Dr. Rübsamen-Schaeff and Dr. Zimmermann unveiled a module of AiCuris Letermovir project as part of the German Future Prize exhibition at the Deutsches Museum in Munich. -

    Poništi
  16. 21. srp 2019.
    Poništi
  17. 15. srp 2019.

    It has been a pleasure to host our partners from to our kick-off meeting. Committed to fight by combining Lysando's Artilysin technology with ' experience in bringing drugs to the market.

    Poništi
  18. 9. srp 2019.

    What a fantastic news! A giant step on your way! Congrats!

    Poništi
  19. proslijedio/la je Tweet
    9. srp 2019.
    Poništi
  20. 9. srp 2019.

    Congrats to our friends and colleagues at ! Great achievement!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·